Below are the most recent publications written about "Anticoagulants" by people in Profiles.
-
Ibrahim A, Shalabi L, Zreigh S, Ramadan S, Mourad S, Eljadid G, Beshr M, Abdelaziz A, Elhadi M, Sabouret P, Mamas M. Comparative Efficacy and Safety of Low-Dose Direct Oral Anticoagulants Versus Dual Antiplatelet Therapy Following Left Atrial Appendage Occlusion in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. Catheter Cardiovasc Interv. 2025 05; 105(6):1311-1319.
-
Musmar B, Salim HA, Roy JM, Adeeb N, Fuleihan AA, Atallah E, Sizdahkhani S, Koduri S, Karadimas S, Baba BE, Howard BM, Grossberg JA, Scott KW, Burkhardt JK, Srinivasan VM, Erazu F, Hanel RA, Amllay A, Matouk C, MacNeil A, Chalouhi N, Gomez-Paz S, Grandhi R, Jaikumar V, Levy E, Siddiqui A, Klaiman M, Delgado J, Hoffman H, Arthur A, Hasan DM, Notarianni C, Cuellar HH, Guthikonda B, Morcos J, Tjoumakaris SI, Gooch MR, Rosenwasser RH, Jabbour P. The Impact of Postprocedural Anticoagulant Use in Patients Undergoing Woven EndoBridge: A Multicenter Propensity Score-Matched Study. Transl Stroke Res. 2025 Oct; 16(5):1486-1495.
-
Jason MJ, Marzec LN, Piccini JP, Shrader P, Pieper KS, Blanco RG, Fonarow GC, Gersh BJ, Ho PM, Hylek E, Kowey PR, Mahaffey KW, Steinberg BA, Peterson ED, Allen LA. Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Int J Cardiol. 2025 Feb 15; 421:132912.
-
Mandloi S, Nunes K, Sina EM, Benedict PA, Kahn C, Duffy A, Shing SR, Urdang ZD, Rosen M, Toskala E, Rabinowitz MR, Nyquist GG. Epistaxis Risk in Patients Treated With Left Atrial Appendage Occlusion Versus Oral Anticoagulation. Laryngoscope. 2025 May; 135(5):1636-1641.
-
Leung HHL, Ahmadi Z, Lee B, Casey J, Ratnasingam S, McKenzie SE, Perdomo J, Chong BH. Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments. Blood Adv. 2024 11 26; 8(22):5744-5752.
-
Halawi H, Sabawi MM, Rizk E, Mahmoud AA, Petkova JH, Hui SR, Srour N, Donahue KR. Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity. J Thromb Thrombolysis. 2025 Feb; 58(2):210-219.
-
Witte AB, Van Arendonk K, Bergner C, Bantchev M, Falcone RA, Moody S, Hartman HA, Evans E, Thakkar R, Patterson KN, Minneci PC, Mak GZ, Slidell MB, Johnson M, Landman MP, Markel TA, Leys CM, Cherney Stafford L, Draper J, Foley DS, Downard C, Skaggs TM, Lal DR, Gourlay D, Ehrlich PF. Venous Thromboembolism Prophylaxis in High-Risk Pediatric Trauma Patients. JAMA Surg. 2024 Oct 01; 159(10):1149-1156.
-
Jain SS, Mahaffey KW, Pieper KS, Shimizu W, Potpara T, Ruff CT, Kamel H, Lewis BS, Cornel JH, Kowey PR, Horrow J, Strony J, Plotnikov AN, Li D, Weng S, Donahue J, Gibson CM, Steg PG, Mehran R, Weitz JI, Johnston SC, Hankey GJ, Harrington RA, Lam CSP. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design. Am Heart J. 2024 Nov; 277:145-158.
-
Johnson LS, Benz AP, Shoamanesh A, Eikelboom JW, Ezekowitz M, Giugliano RP, Wallentin L, Ruff CT, Lopes RD, Jolly S, Whitlock R, Granger CB, Connolly S, Healey JS. Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF. J Am Heart Assoc. 2024 Sep 03; 13(17):e034758.
-
Kevu E, Carnish E. Comprehensive Stroke Management: a Guide for Hospitalists. Postgrad Med. 2024 Sep; 136(7):694-701.